These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6452215)

  • 1. Suppressor factor from tumor-allosensitized spleen cells--its effect on in vitro proliferation of tumor cells and in vivo skin allograft survival.
    Argyris BF
    Cell Immunol; 1981 Jan; 57(1):62-72. PubMed ID: 6452215
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of specific suppressor cells with heat-treated allogeneic tumor cells.
    Chiu KM; Faanes RB; Choi YS
    Cell Immunol; 1980 Feb; 49(2):283-92. PubMed ID: 6444368
    [No Abstract]   [Full Text] [Related]  

  • 3. Further characterization of macrophage adsorption of suppressor cell activity from tumor-allosensitized spleen.
    Zografos-Miller LE; Argyris BF
    Transplantation; 1983 Jun; 35(6):593-600. PubMed ID: 6223418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of suppressor cells obtained from tumor-allosensitized adult and untreated neonatal mice.
    Argyris BF
    Dev Comp Immunol; 1985; 9(1):131-40. PubMed ID: 3158560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M; Argyris BF
    Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting suppressor cell activity in tumor-allosensitized mice.
    Argyris BF
    J Natl Cancer Inst; 1980 Apr; 64(4):959-66. PubMed ID: 6445017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of the naturally occurring, newborn spleen-associated suppressor cells. A mixed monocyte/mast cell population with separable suppressor activities.
    Peeler K; Wigzell H; Peck AB
    Scand J Immunol; 1983 May; 17(5):443-53. PubMed ID: 6222470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decay of memory of cell-mediated cytotoxicity after primary sensitization in vivo against a tumor allograft.
    Jones KH; Adler WH
    Immunol Commun; 1978; 7(6):645-59. PubMed ID: 154468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorption of suppressor cell activity on mouse macrophage monolayers.
    Argyris BF; Cotellessa A
    Transplantation; 1979 Nov; 28(5):372-6. PubMed ID: 160634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on suppressor cell activity in the spleen of neonatal mice.
    Argyris BF
    Cell Immunol; 1979 Dec; 48(2):398-406. PubMed ID: 159785
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.
    Maier T; Levy JG; Kilburn DG
    Cell Immunol; 1980 Dec; 56(2):392-9. PubMed ID: 6451300
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro expression of secondary antitumor immunity by in vitro tumor-sensitized T cells: inhibition by tumor-induced suppressor T cells.
    Kaymakcalan Z; Spitalny GL; Bursuker I
    Cancer Immunol Immunother; 1987; 25(2):69-74. PubMed ID: 2959361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of suppressor T cells by antilymphocyte serum treatment in mice.
    Maki T; Simpson M; Monaco AP
    Transplantation; 1982 Dec; 34(6):376-81. PubMed ID: 6186056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of mouse skin allograft survival by cloned veto suppressor cells.
    Takahashi T; Maki T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):192-3. PubMed ID: 1824972
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 20. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.